WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) reported that it has closed its previously announced private placement of preferred stock and warrants. The Company sold to a healthcare dedicated institutional investor 13,800 shares of Series C convertible preferred stock at a

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Senior Vice President and Chief Commercial Officer Frank McGillin will present on Quell ® Wearable Pain Relief Technology™ during the 16th Annual Diabetes Technology Meeting, November 10-12 , in

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D ., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29 th Annual Meeting of The Japan Society of Diabetic Complications to be held in Tokyo on October 3 and

WALTHAM, Mass. , Jan. 04, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will participate in a panel at the Digital Health Summit at CES 2018.  The panel, “The Vicious Spiral: How Will the Opioid

Company is Addressing Diabetes-Related Nerve Disease

Discussion of Diagnosis and Treatment of Diabetic Peripheral Neuropathy WALTHAM, Mass. --(BUSINESS WIRE)-- Shai N. Gozani , M.D., Ph.D, President and Chief Executive Officer of NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological

Importance of Managed Care Sector is Highlighted

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that it is celebrating its twenty year anniversary. NeuroMetrix was incorporated in Cambridge, Massachusetts on June 6, 1996 as a spin-off from the Harvard-MIT Division of Health Sciences and Technology .

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) announced today that to celebrate having reached 10,000 fans for Quell ® Pain Relief on Facebook, it will give away a contest prize each day during September which is Pain Awareness Month.

Waltham -based company to exhibit its wearable device for widespread pain relief ORLANDO, Fla. --(BUSINESS WIRE)-- Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell ® , its FDA -cleared, 100% drug-free